The countdown to type 1 diabetes: when, how and why does the clock start? Anette-Gabriele Ziegler Review Open access 26 May 2023 Pages: 1169 - 1178
Effects of postprandial exercise on blood glucose levels in adults with type 1 diabetes: a review Simon HelleputteJane E. YardleyPatrick Calders Review 04 April 2023 Pages: 1179 - 1191
The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity Evan L. ReynoldsMaya WatanabeBrian C. Callaghan Article 14 March 2023 Pages: 1192 - 1207
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial Christian LaugesenAjenthen G. RanjanKirsten Nørgaard Article Open access 11 April 2023 Pages: 1208 - 1217
Childhood adversity and risk of type 2 diabetes in early adulthood: results from a population-wide cohort study of 1.2 million individuals Leonie K. ElsenburgJessica BengtssonNaja H. Rod Short Communication 20 April 2023 Pages: 1218 - 1222
Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes Melanie LloydJedidiah MortonZanfina Ademi Article Open access 18 March 2023 Pages: 1223 - 1234
Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study Yu HatanoLisa B. VanWagnerYuichiro Yano Article 21 March 2023 Pages: 1235 - 1246
Investigating causality in the association between DNA methylation and type 2 diabetes using bidirectional two-sample Mendelian randomisation Diana L. Juvinao-QuinteroGemma C. SharpHannah R. Elliott Article Open access 19 May 2023 Pages: 1247 - 1259
Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH Josephine H. LiLaura N. BrennerJose C. Florez Article 26 May 2023 Pages: 1260 - 1272
The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes Alicia Huerta-ChagoyaPhilip SchroederJosep M. Mercader Article Open access 06 May 2023 Pages: 1273 - 1288
Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover Mi HuangMelina ClaussnitzerPaul W. Franks Article Open access 12 May 2023 Pages: 1289 - 1305
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models Vyron GorgogietasBahareh RajaeiMariana Igoillo-Esteve Article Open access 30 March 2023 Pages: 1306 - 1321
Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice Wanbao YangWang LiaoShaodong Guo Article 19 May 2023 Pages: 1322 - 1339
Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes Alison D. McNeillyJennifer R. Gallagheron behalf of the Hypo-RESOLVE Consortium Article Open access 04 April 2023 Pages: 1340 - 1352